<b>Determination of lactate dehydrogenase (LDH) and <em>Bcr-Abl</em> transcript in the follow-up of patients with chronic myeloid leukemia</b> - doi: 10.4025/actascihealthsci.v32i2.6408

• Váldodahkkit: Roberto Iemirsu Tatakihara (Dahkki), Marla Karine Amarante (Dahkki), Mateus Nóbrega Aoki (Dahkki), Julie Massayo Maeda Oda (Dahkki), Thiago Cezar Fujita (Dahkki), Maria Angelica Ehara Watanabe (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Universidade Estadual de Maringá, 2010-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Chronic myeloid leukemia (CML) is a malignant myeloproliferative disorder that originates from a pluripotent stem cell characterized by abnormal release of the expanded, malignant stem cell clone from the bone marrow into the bloodstream. The vast majority of patients with CML present Bcr-Abl transc...